These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34872776)

  • 1. Changes in rectal cancer treatment after the introduction of a national screening program; Increasing use of less invasive strategies within a national cohort.
    Giesen LJX; Olthof PB; Elferink MAG; van Westreenen HL; Beets GL; Verhoef C; Dekker JWT
    Eur J Surg Oncol; 2022 May; 48(5):1117-1122. PubMed ID: 34872776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal cancer: Watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth.
    Al-Najami I; Jones HJ; Dickson EA; Muirhead R; Deding U; James DR; Cunningham C
    Surg Oncol; 2021 Jun; 37():101574. PubMed ID: 33853031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer.
    van Erning FN; Rutten HJ; van den Berg HA; Lemmens VE; van Halteren HK
    Eur J Surg Oncol; 2015 Dec; 41(12):1630-5. PubMed ID: 26437853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends and Variation in the Use of Radiotherapy in Non-metastatic Rectal Cancer: a 14-year Nationwide Overview from the Netherlands.
    Verrijssen AE; Evers J; van der Sangen M; Siesling S; Aarts MJ; Struikmans H; Bloemers MCWM; Burger JWA; Lemmens V; Braam PM; Elferink MAG; Berbee M
    Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):221-232. PubMed ID: 38336504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project.
    Pellino G; Alós R; Biondo S; Codina-Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; Cervantes A; García-Granero E;
    Eur J Surg Oncol; 2021 Feb; 47(2):276-284. PubMed ID: 32950316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial].
    Wang L; Zhao YM; Sun TT; Xu YL; Li SJ; Zhang XY; Cai Y; Li YH; Li ZW; Chen PJ; Peng YF; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):258-265. PubMed ID: 32192305
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of clinical T1 rectal cancer in the Netherlands; a population-based overview of clinical practice.
    Verseveld M; Verver D; Noordman BJ; Pouwels S; Elferink MAG; de Graaf EJR; Verhoef C; Doornebosch PG; de Wilt JHW
    Eur J Surg Oncol; 2022 May; 48(5):1153-1160. PubMed ID: 34799230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant radiotherapy for rectal cancer management.
    Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M
    World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre.
    Hagemans JAW; van Rees JM; Alberda WJ; Rothbarth J; Nuyttens JJME; van Meerten E; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2020 Mar; 46(3):448-454. PubMed ID: 31761506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 14. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?
    Hughes R; Harrison M; Glynne-Jones R
    Acta Oncol; 2010 Apr; 49(3):378-81. PubMed ID: 20151936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010.
    Guren MG; Kørner H; Pfeffer F; Myklebust TÅ; Eriksen MT; Edna TH; Larsen SG; Knudsen KO; Nesbakken A; Wasmuth HH; Vonen B; Hofsli E; Færden AE; Brændengen M; Dahl O; Steigen SE; Johansen MJ; Lindsetmo RO; Drolsum A; Tollåli G; Dørum LM; Møller B; Wibe A
    Acta Oncol; 2015 Nov; 54(10):1714-22. PubMed ID: 25924970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
    Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
    Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol.
    Vatandoust S; Wattchow D; Sposato L; Michael MZ; Leung J; Gormly K; Chen G; Symonds EL; Tie J; Papanicolas LE; Woods S; Gebski V; Mead K; Kuruni A; Karapetis CS
    BMC Cancer; 2022 Mar; 22(1):222. PubMed ID: 35232427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological outcome after local treatment for early stage rectal cancer.
    Witjes CDM; Patel AS; Shenoy A; Boyce S; East JE; Cunningham C
    Surg Endosc; 2022 Jan; 36(1):489-497. PubMed ID: 33544250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominoperineal resection for rectal cancer at a specialty center.
    Nissan A; Guillem JG; Paty PB; Douglas Wong W; Minsky B; Saltz L; Cohen AM
    Dis Colon Rectum; 2001 Jan; 44(1):27-35; discussion 35-6. PubMed ID: 11805560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.